We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...
Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
Robert F. Kennedy Jr. said he would follow the Trump administration’s orders on prescription drug price negotiations, a ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
(Under Azar, Eli Lilly tripled the price of its top-selling insulin drug.) But President Joe Biden's Inflation ... as the ...
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...